control of the level of protein expression in cells can yield quantitative and temporal information on the role of a given gene in normal cellular physiology and on exposure to chemicals and drugs. This is particularly relevant to liver cells, in which the expression of many proteins, such as phase I and phase II drug-metabolizing enzymes, vary widely between species, among individual humans, and on exposure to xenobiotics. The most widely used gene regulatory system has been the tet-on/off approach. Although a second-generation tet-on transactivator was recently described, it has not been widely investigated for its potential as a tool for regulating genes in cells and particularly in cells previously recalcitrant to the first-generation tet-on approach, such as hepatocyte-derived cells. Here we demonstrate the development of two human (HepG2 and HuH7) and one mouse (Hepa1c1c7) hepatoma-derived cell lines incorporating a second-generation doxycycline-inducible gene expression system and the application of the human lines to control the expression of different transgenes. The two human cell lines were tested for transient or stable inducibility of five transgenes relevant to liver biology, namely phase I (cytochrome P-450 2E1; CYP2E1) and phase II (glutathione S-transferase P1; GSTP1) drug metabolism, and three transcription factors that respond to chemical stress [nuclear factor erythroid 2 p45-related factors (NRF)1 and 2 and NFKB1 subunit of NF-B]. High levels of functional expression were obtained in a time-and dose-dependent manner. Importantly, doxycycline did not cause obvious changes in the cellular proteome. In conclusion, we have generated hepatocyte-derived cell lines in which expression of genes is fully controllable. liver cells; proteins; CYP2E1; NRF2; GSTP1 THE USE OF LIVER-DERIVED CELLS is an integral part of research in molecular hepatology. These cells provide an invaluable biological tool that can be controlled more easily and more cheaply than transgenic animals. However, at present, liver cell systems are hampered by the fact that immortalized cell lines become dedifferentiated and therefore lose their metabolic capacity (40). Furthermore, their ability to model normal human liver cells is compromised by the intrinsic variability in drug-metabolizing enzymes inherent to the population. Thus the ability to precisely control the cellular levels of key metabolic enzymes or other proteins with critical cell functions would be an invaluable aid in obtaining liver-derived cells that more closely resemble normal hepatocytes and in better defining the roles of particular liver proteins.
man liver cells is compromised by the intrinsic variability in drug-metabolizing enzymes inherent to the population. Thus the ability to precisely control the cellular levels of key metabolic enzymes or other proteins with critical cell functions would be an invaluable aid in obtaining liver-derived cells that more closely resemble normal hepatocytes and in better defining the roles of particular liver proteins.
The most promising and widely used technique for regulating heterologous gene expression has been the tetracyclineregulated gene expression system (16) . The technique consists of consecutive transfections of the target cells with two transgenes, the first of which encodes a tetracycline-controlled transactivator protein (tTA) and the second of which is the modified gene of interest, with a tetracycline response element (TRE) in its 5Ј regulatory sequence. In the presence of tetracycline, or typically its more stable derivative doxycycline (dox), tTA is prevented from binding the TRE of its target gene and the system is inactive (tet-off system; Ref. 16) . In an alternative version of this system, a mutated tTA, i.e., reverse tTA (rtTA), is used, whereby amino acid substitutions in the tTA protein yield a transcriptional activator in the presence of dox (17, 20, 32) . This tet-on system has a number of inherent advantages over the tet-off approach: dox does not need to be permanently present in the cell environment to maintain the repressed state, as is the case with the tet-off cells. In addition, the need to remove all of the dox to activate genes has caused problems of variability in gene induction experiments using the tet-off system.
Although the tet-on approach circumvents these difficulties, the use of the first-generation tet-on system has been hampered by the phenomenon of "leakiness," which was sometimes observed to cause high background expression of inducible genes in the absence of dox (11, 12) , and also the unsuitability of the tet-on approach in certain cell types, such as hepatocytes (13, 38) . To address these issues, various modifications of the tet-on system have been tested, e.g., use of a silencer protein to reduce noninduced expression (12) and synthesis of a novel mutant rtTA protein (41) . This second-generation rtTA, termed rtTA2 dox (41) . It has been tested in transgenic animals (26, 44 ) but has still not been widely investigated for its potential as a tool for regulating genes in cells and particularly in cells previously recalcitrant to the first-generation tet-on approach, such as hepatocyte-derived cells. We have therefore compared the applicability of this novel system relative to the first-generation tet-on approach in two human and one mouse hepatoma cell lines and found that the new transactivator enables the generation of hepatocyte-derived cell lines in which expression of genes is fully controllable.
EXPERIMENTAL PROCEDURES

Recombinant Plasmids
The rtTA2 S -M2 plasmid was described previously (10) . The protein expressed from this plasmid is activated by dox to form a transcriptional activator capable of triggering transcription of genes with a series of tet operator (tetO) sequences aligned to form a TRE coupled to a cytomegalovirus promoter upstream of their transcription start site. Sequences corresponding to the full-length coding sequences of the genes investigated were obtained as follows: human glutathione S-transferase (GST) P1 (GSTP1) was amplified from a human lymphocyte cDNA library; mouse nuclear factor erythroid 2 p45-related factor (NRF)2 was amplified from a mouse NRF2 expression vector (kind gift of Ken Itoh and Masayuki Yamamoto, University of Tsukuba, Japan); human NFKB1 subunit of NF-B and human NRF1 were amplified from IMAGE clones obtained from the Medical Research Council (Cambridge, UK). PCR amplicons of each of these genes were obtained with MluI and NotI restriction tags to enable directional cloning into corresponding sites in the multiple cloning sequence of the dox-responsive pTRE2-hyg vector (Clontech, Oxford, UK). The identity and orientation of each of the coding sequences within each of the recombinant plasmids were checked by DNA sequencing of each of the strands. The rabbit cytochrome P-450 2E1 (CYP2E1) coding sequence within the dox-responsive vector pUHD10 -3 was a kind gift of Lisa Bleyle and Dennis Koop (University of Oregon, Portland, OR) and was described previously (21) .
Cell Transfection
One day before transfection, cells were seeded at a density of 0.5 ϫ 10 6 cells/well in six-well culture plates. Stable transfection of the rtTA2 S -M2 plasmid into the human hepatoma cell lines HuH7 and HepG2 and the mouse hepatoma cell line Hepa1c1c7 was carried out with Genejuice reagent (Novagen, Nottingham, UK) essentially as described by the manufacturer [1 g/well at a ratio of 1:3 of DNA to Genejuice (wt/vol)]. Two days after transfection, cells were selected for rtTA2 S -M2 integration with G418 antibiotic treatment for 3-4 wk (500 g/ml for each cell line). Clones were selected for low basal activity and high absolute levels of induction in the luciferase assay, expanded, and cryopreserved. Transient transfections were carried out with Genejuice. Cells were lysed 16, 24, or 48 h after transfection and monitored for expression of the genes of interest. Stable transfections with the genes of interest were carried out as for the rtTA2 S -M2 plasmid transfections, using hygromycin for selection (250 g/ml for each of the clones tested).
Luciferase Assay
Clones were tested for dox inducibility by transient transfection of 0.5 ϫ 10 5 cells of each clone seeded in flat-bottomed 96-well plates, with 50 ng of pTRE2-luc dox-dependent luciferase reporter plasmid (Clontech). Four hours after transfection, clones were treated or not with 1 g/ml dox in growth medium for at least 16 h. Cells in each well were then lysed with cell lysis buffer (Promega, Southampton, UK), BrightGlo luciferase substrate buffer (Promega) was added, and the chemiluminescence was measured in a plate reader (PerkinElmer, Pangbourne, UK) and recorded as arbitrary light units.
Western Blotting
Cell lysates were obtained from cells transiently or stably transfected with genes of interest by lysis in a Triton X-100 cell lysis buffer, followed by centrifugation at 1,500 g to pellet and remove the nuclei. Protein concentrations of the enucleated lysates were estimated by the method of Bradford (3) . Equal amounts of protein (typically 10 g) were separated by denaturing electrophoresis and detected and quantified by standard procedures.
Immunofluorescence Detection
A stable rtTA2 S -M2-HuH7 clone transiently transfected with the CYP2E1-inducible plasmid was grown in a LabTek II chamber slide system and treated or not with 1 g/ml dox for 16 h. Cells were fixed in 4% paraformaldehyde and permeabilized with 0.2% Triton X-100. After blocking with 10% fetal bovine serum in PBS, they were incubated with the anti-CYP2E1 antiserum (diluted 1:200 in 2% fetal bovine serum in PBS) at 37°C for 1 h, washed with PBS, stained with fluorescein isothiocyanate-conjugated anti-rabbit antibody (diluted 1:200 in 2% fetal bovine serum in PBS), and then washed with PBS. Immunofluorescence microscopy analysis was performed with a Nikon E600. For detection of stably transfected NRF2, the HepG2-NRF2-WT19 cells were grown in a LabTek II and treated or not with 1 g/ml dox for 16 h. Cells were then fixed, permeabilized, and stained with anti-NRF2 antiserum. Hoechst 33258 stain was included in the final washes of the cells to visualize the nuclei. Immunofluorescence confocal microscopy analysis was performed with a Leica SP2 AOBS.
Analysis of CYP2E1 Activity
For the measurement of p-nitrophenol hydroxylation by the method of Reinke and Moyer (35) , cells were incubated at 37°C for 2 h in 100 l of Hanks' buffered saline containing 200 M p-nitrophenol. To this was added 50 l of 0.06 M perchloric acid. After vortexing and centrifugation, 100 l of the supernatant was added to a 96-well plate with 50 l of 10 M sodium hydroxide. The plate was read at 550 nm and quantified with p-nitrocatechol standards. For the measurement of chlorzoxazone hydroxylation, a method adapted from that of Peter et al. (34) was used. Briefly, cells were suspended in 6 ml of hepatocyte incubation buffer containing chlorzoxazone (200 M) and incubated at 37°C, with gentle shaking, for 3 h. The reactions were terminated by the addition of 6 ml of acetonitrile and internal standard (2-benzoxazolinone) and analyzed by reverse-phase HPLC.
Analysis of GST Activity
Aliquots of lysates were placed in a 96-well plate with 320 l of potassium phosphate buffer (0.1 M; pH 6.5) containing 1.5 mM 2,4-dinitrochlorobenzene (DNCB) and 1.5 mM GSH. The formation of the DNCB-glutathione conjugate was determined from the increase in absorbance at 340 nm, according to Habig and Jakoby (19) .
Isotope-Coded Affinity Tag Analysis
A cell extract enriched for microsomal proteins was prepared from a CYP2E1-expressing clone by differential centrifugation (23) . An aliquot of 100 g was denatured, reduced, labeled with heavy isotopecoded affinity tag reagent, and digested with trypsin per the manufacturer's instructions (Applied Biosystems) (18) . After cation exchange and avidin affinity chromatography, the sample was subjected to mass spectrometry (MS/MS) analysis.
Two-Dimensional Gel Electrophoresis
Cells were incubated under the indicated conditions, washed twice with ice-cold PBS, harvested in PBS by gentle scraping, and then washed several times in PBS. The final cell pellet was lysed in 70 l of isoelectric focusing sample buffer [7 M urea, 2 M thiourea, 4% (wt/vol) 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 40 mM Tris, 1% (wt/vol) DTT], subjected to a freeze-thaw cycle at Ϫ70°C, and centrifuged at 17,000 g and 4°C for 30 min. The supernatant was assayed for protein content and separated by twodimensional (2D)-PAGE, following the method of Gorg et al. (15) . The gels were stained with colloidal Coomassie blue and scanned with a GS-710 imaging densitometer (Bio-Rad, Hemel Hempstead, UK).
Characterization of Protein Spots
The putative GSTP1 was excised from the 2D gel and subjected to in-gel tryptic digestion by the method of Courchesne and Patterson (6) before MS. Confirmation of identity of the protein was achieved by nano-liquid chromatography (LC)-electron spray ionization (ESI)-MS/MS analysis.
3-(4,5-Dimethyl-2-Thiazolyl)-2,5-Diphenyl-2H-Tetrazolium Bromide Assay for Cell Viability
Cells were seeded at a density of 1 ϫ 10 4 /well in a 96-well plate and treated with dox for 24 h. 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) was then added to each well (to a final concentration of 1 g/ml) and incubated at 37°C for 4 h. An equal volume of lysis buffer was then added to the wells and incubated at 37°C for 4 h. Absorbance in each well was then measured at 570 nm.
RESULTS
Development of dox-Inducible Hepatoma Cells
We successfully established dox-inducible hepatoma cells with the second-generation tet-on activator in two human cell lines, HepG2 and HuH7, and a mouse hepatoma cell line, Hepa1c1c7. As found previously by other groups, we were unable to develop tet-on inducible hepatocyte-derived cells with the conventional first-generation rtTA tet-on activator and/or the silencer protein, tTS E (data not shown). It is known that overexpression of the VP16 domain in the rtTA protein can titrate out components of the normal transcription machinery, resulting in "squelching" of components of general transcription, e.g., TFIIB (28), TFIID (39) , and TFIIH (43) . We therefore tested the applicability of a recently described transcriptional modulator, rtTA2 S -M2, in which the full-length VP16 domain has been substituted with a multimerized acidic peptide derived from VP16 itself and the sequence has been optimized to improve expression (41) . Stable clones were selected and tested for dox inducibility by transient transfection with a luciferase expression plasmid under the control of a TRE. Representative screening experiments are shown in Fig.  1 . These data indicate that rtTA2 S -M2 is suitable for use as a regulator within the hepatocyte-derived cells tested. The selected clones from each of the cell types have much higher levels of expression of the luciferase reporter, as well as greater differences in the fold induction, compared with our data from the conventional rtTA activator alone or in combination with the tTS E silencer. From low basal activity, the induction of clones that were considered to be potentially useful ranged from Ͼ10-fold up to Ͼ1,000-fold.
Applicability of Inducible Cells to Expression of Liver-Relevant Genes
Transient expression. We next tested some of the selected human clones for inducibility of transiently transfected heterologous genes known to be involved in a number of different pharmacologically relevant processes in the liver, namely phase I metabolism, i.e., CYP2E1, and phase II metabolism, i.e., GSTP1 and transcription factors responsible for sensing chemical stress signals, i.e., NRF2, NRF1, and the NFKB1 subunit of NF-B. Expression of a rabbit CYP2E1 sequence was successfully achieved in our HepG2 and Huh7 clones (Fig.  2A) ; parental HepG2 cells are known not to express CYP2E1 (7); nothing has been published regarding expression of CYP2E1 in HuH7 cells. We did not detect CYP2E1 in either cell type before transfection, as shown by Western blotting and immunofluorescence staining (Fig. 2A) . On the basis of enzyme kinetic parameters, few differences exist among mammalian species with respect to activity of the CYP2E1 enzyme (2); therefore, the rabbit CYP2E1 was deemed a useful model of human CYP2E1 activity. Inducible expression was also achieved for human GSTP1 in our HepG2 clones (see Fig. 2B ), the parental form of which does not express detectable GSTP1 (30) . Induction over 48 h did not increase expression above that observed after 24 h. Transient transfection of mouse NRF2 also yielded dox-inducible expression of this transcription factor (Fig. 2C) . A mouse NRF2 sequence was used here because these cells express endogenous NRF2 (this is barely detectable where cells have not been exposed to any chemical stress because the protein is constitutively degraded before activation; for reviews see Refs. 31 and 25). Levels of expression within our cells appeared comparable with those achieved with a positive control tet-on rtTA2 S -M2-transfected HeLa clone, HR2sM2, as previously described (Ref. 24 ; compare NRF2 induced in the HuH7 clone with that in the HeLa clone in Fig. 2C ). Transient transfection of genes encoding human NRF1 and NFKB1 also yielded dox-inducible expression of these transcription factors (Fig. 2, D and E) , indicating the utility of these cells for a variety of genes.
Stable inducible expression. To further validate this approach, we constructed transgenic cells derived from one of our HepG2 rtTA2 S -M2 clones that stably express an inducible form of CYP2E1, GSTP1, or NRF2. Several stable CYP2E1-inducible clones were isolated (see Fig. 3 ). Clones 4 and 5 expressed levels of CYP2E1 protein and CYP2E1-dependent p-nitrophenol hydroxylation less than but comparable to those found in mouse liver and cryopreserved rat hepatocytes, respectively (Fig. 3 ). Microsomes were also prepared from clone 4 24 h after induction with 1 g/ml dox to validate the identity of the induced CYP2E1 protein by MS/MS analysis as shown in Fig. 4 . Maximal expression of the protein was observed after 16 -24 h of exposure to dox (Fig. 5A ) at 1-3 g/ml dox (Fig.  5, B and C) . The maximal rate of formation of 6-hydroxychlorzoxazone by the clone 4 cells was 399 pmol⅐min Ϫ1 ⅐mg total cellular protein Ϫ1 (equivalent to 66 pmol⅐min Ϫ1 ⅐10 6 cells Ϫ1 ), 24 h after exposure to 3 g/ml dox.
The GSTP1 clone HepG2-PWT2 that resulted from this work is maximally inducible for GSTP1 after ϳ16-h exposure to 1 g/ml dox, although GSTP1 can be detected after just 4-h exposure (Fig. 6A) . Maximal GSTP1 expression was observed at 1 g/ml dox (Fig. 6B) , although expression can be seen to be increased above baseline at 10 ng/ml dox. In both time course and dose-response experiments, induction of GSTP1 correlated with its GST activity, measured by DNCB conjugation with glutathione, indicating that the expressed GSTP1 was functionally active.
Expression of GSTP1 was also visualized from within the global cell proteome by 2D gel-based proteomic analysis. Initially, three gels of individual cultures of the HepG2-tet-on parental clone were compared with three gels of the clone treated with 1 g/ml dox for 24 h, both by visual inspection and with semiautomated ImageMaster spot analysis software. Importantly, no statistically significant differences were apparent between the sets of untreated cells and the sets of cells treated with dox, indicating a probable absence of nonspecific effects on global protein expression at the level of dox treatment necessary for maximal target gene induction (data not shown). Paradigm gels showing the lack of differences after treatment are shown in Fig. 7A . In the HepG2-PWT2 clone, GSTP1 was detected after 4 h of dox treatment (1 g/ml) (Fig.  7B, bold circled spots) . After 24 h of dox treatment, GSTP1 in this clone was the most abundant cellular protein within this analysis. The identity of the induced protein spot was confirmed by excision, in-gel digestion, and LC-MS analysis (Fig.  7C) . Expression of the GSTP1 leads to a large number of changes in the expression or posttranslational modification of cellular proteins, as can be seen from the two circled changes in Fig. 7B , as well as the differences apparent in the boxed parts of the gels (Fig. 7B ). These differences are not identical between the 4-h and 24-h induced cell samples, indicating the likely time-and/or GSTP1 abundance dependence of these differences.
The ability to regulate an NRF2-expressing clone, HepG2-NRF2-19, was also high, both temporally and dose dependently (see Fig. 8, A and B) . NRF2 was not induced in the HepG2-tet-on parental clone at the levels of dox used here (data not shown).
Expression of the protein, confirmed by immunofluorescence microscopy, was visible throughout the cells where heterologous NRF2 was induced (see Fig. 8C ); this was also confirmed by Western blot analysis demonstrating high levels of nuclear NRF2 in the cells treated with dox and undetectable levels of nuclear NRF2 in the absence of treatment (data not shown). Importantly, the rtTA2 S -M2 activator appears to act homogenously, because most of the cells were inducible (Fig.  8C) . The induction of NRF2 was shown to be functionally relevant, because expression of a paradigm NRF2-dependent cell defense gene, glutamate cysteine ligase catalytic subunit (GCLC), was upregulated coincidentally with NRF2 activation (Fig. 8D) .
The inducible CYP2E1-, GSTP1-, and NRF2-expressing clones have been cryopreserved and regrown for as many as 25 S -M2 tet-on construct enables conventional transfection and selection of highly doxycycline (dox)-regulatable hepatoma cell clones. HuH7 (A), HepG2 (B), and Hepa1c1c7 (C) cells were transfected with rtTA2 S -M2, selected with G418 antibiotic, and expanded and tested for tetracycline response element (TRE)-dependent luciferase activity after transient transfection with a TRE-luciferase reporter and after treatment, or not, with 1 g/ml dox, for 24 h. Clones marked with an asterisk were retested and verified as dox inducible with the same assay and retained for further investigation.
passages without obvious loss of induction, confirming the robustness of the rtTA2 S -M2 activator approach in these cells (data not shown). rtTA2 S -M2-expressing clones of each cell type were also checked to ensure that the levels of dox used for induction (normally Յ1 g/ml) did not cause cytotoxicity. In a MTT assay, no toxicity was observed up to 3 g/ml dox treatment (3 times that generally required for maximum induction) after 24 h of exposure (data not shown).
Fig. 2. The rtTA2
S -M2-expressing hepatoma cell clones are suitable for the dox-regulatable expression of 5 paradigm genes. Various rtTA2S-M2-transfected clones were transiently transfected with a TRE-dependent rabbit cytochrome P-450 2E1 (CYP2E1) construct (A), a human TRE-glutathione S-transferase P1 (GSTP1) construct (B), a mouse TRE-nuclear factor erythroid 2 p45-related factor (NRF)2 construct (C), a human TRE-NRF1 construct (D), or a human TRE-NFKB1 construct (E). Cells were treated or not with dox (1 g/ml) for 16 h immediately after transfection. Enucleated cell lysates were then prepared from the cells and analyzed by Western blotting, or for CYP2E1 cells were also fixed and permeabilized before immunofluorescent microscopy with an anti-CYP2E1 antibody. Where possible, a positive/negative control was included on the electrophoretic gels to help correctly assign proteins, and the predicted molecular weight of the target proteins was also taken into account. Cell proteins cross-reacting with antibodies were termed nonspecific because of their migration at molecular weights not predicted from the estimated size of the expected proteins or their noncomigration with positive controls and were always found to be cross-reacting because of their high abundance as assessed by Ponceau red staining of the membranes after protein transfer. The positive/negative controls were as follows: GSTP1 negative and positive controls were mouse liver homogenate samples obtained from GSTP1Ϫ/Ϫ and wild-type animals; NRF2 negative and positive controls were lysates of 293T cells transfected with a pcDNA3.1 vector or the same vector containing the mNRF2 coding sequence, respectively. Lanes labeled "mock" were treated with transfection reagent alone.
DISCUSSION
Expression of a specific heterologous protein that can be regulated in a temporal and dose-dependent manner has clear benefits for the development of cell lines to investigate the precise role and function of specific proteins compared with conventional transgenic liver cell lines. As well as the obvious advantage of providing a genetically identical control with which to compare the cells in which the gene has been induced, the transitory effects of expression, which might otherwise be missed with conventional gene transfection, can be detected with such a system. Furthermore, the ability to precisely control levels of a particular protein, by titrating the concentration of dox, will allow us to explore function at various levels of expression and to model human variation in liver protein expression and its relevance to drug disposition and toxicity. Clearly, this system at the highest inducing doses of dox may result in supraphysiological levels of expression of functional proteins, as can be seen with the highly abundant GSTP1 produced in the HepG2-GSTP-WT2 clone (Fig. 7B) . However, the versatility of the control system allows a downtuning of the expression to more physiological levels, simply by treating with lower levels of dox.
Our approach yields robust and highly inducible hepatocytederived cells, which appear to be excellent host cells for the genes that were tested. We did not find it necessary to use a virally mediated gene transfer technique, as was recently shown for establishment of an alternative tet-on regulation system in HepG2 cells (27) . Our method is therefore amenable to development in most laboratories, without the need for specialized vector transfection facilities. Each cell line that had been selected for further study exhibited low uninduced and high absolute levels of expression, providing ample scope for precisely controlling gene expression levels, because in each case the extent of dox induction was related directly to dose. In addition, because induction does not rely upon the removal of an inhibitor, long-term culture in the presence of inhibitor is not required, avoiding possible compensatory changes in the cells. To determine the utility of these clones, they were tested with five genes of relevance to liver biology, which were all found to be expressed at the transient level. Stable clones of cells with three of these genes, i.e., CYP2E1, GSTP1, and NRF2, were created, and these exhibited temporal and dose- Fig. 3 . Stable regulatable expression is achievable in an rtTA2 S -M2-HepG2 clone using CYP2E1 as the target gene: selection of clones. A HepG2 dox-inducible clone was stably transfected with a TRE-dependent rabbit CYP2E1 construct. Clones were selected with hygromycin, expanded, and tested for inducibility of CYP2E1 expression at the level of protein expression in 10 g of cell lysate, using an equivalent amount of mouse liver homogenate as a positive control (pos con), and CYP2E1 activity as measured by pnitrophenol (PNP) hydroxylation in 10 ϫ 10 6 cells, using equivalent numbers of rat liver cryopreserved hepatocytes as a positive control. dependent regulation of gene expression. The gene products were expressed to high levels and were shown to be functionally active. With global protein analysis, it was possible to detect many protein changes as a consequence of expression of one of these genes, GSTP1. These changes were related to the duration and/or extent of expression of the GSTP1. In fact, GSTP1 is well recognized as a multifunctional protein, capable not only of conjugation of GSH with a variety of electrophilic compounds (22, 37) but also of modulating other biochemical pathways, such as intracellular signaling processes, including the jun kinase pathway (1, 8, 36) , and activation of the essential antioxidant protein peroxiredoxin (29) . We are therefore presently using this novel system to investigate the nature of the changes observed on GSTP1 induction.
The maximal rate of reaction of our CYP2E1-expressing cells, i.e., 399 pmol 6-hydroxyclorzoxazone formed⅐min Ϫ1 ⅐ mg total cell protein
Ϫ1
, is higher than that reported for the only other known inducible CYP2E1 cell line, i.e., human HeLa tetHeLa2E1-12 cells (21) , which exhibit an activity of 158 pmol⅐min Ϫ1 ⅐mg total cell protein Ϫ1 . Although Chen and Cederbaum (5) previously developed a HepG2 cell line expressing CYP2E1 at approximately 10-fold higher levels than those seen in the HeLa inducible cells, expression of CYP2E1 in these cells caused significant growth retardation effects compared with parental cells. Our system therefore potentially enables the setting of a more physiologically relevant level of expression with which to explore the role of CYP2E1 in drug metabolism and toxicity. . This clone was also tested for its response to increasing concentrations of dox by measuring protein expression by Western blotting (B) and CYP2E1 activity, using 6-hydroxychlorzoxazone (6-OHCZX) as enzyme substrate (C). Similar Western blot data were obtained in at least 2 separate experiments. The activity data in C represent the mean Ϯ SD of 2 independent experiments.
The development of a fully NRF2-inducible cell line may prove useful in further defining the role of this facilitator of cell defense. We (14) and others (4, 9) have shown the importance of NRF2 in the rapid response of the liver to chemical stress elicited by prototypic hepatotoxicants such as acetaminophen. We are presently exploring, with a proteomic approach, the effect of controlling the level of NRF2, to help us define the critical chemical changes in NRF2 and its interacting partners that are thought to be necessary for its activation and the triggering of the cellular defense response.
Importantly, the use of proteomic analysis is to our knowledge the first report of a study of dox induction on the cell proteome and indicates that the levels of dox necessary for protein synthesis do not appear, by visual inspection and semiautomated spot analysis with ImageMaster software of 2D gels, to have a statistically significant effect on the expression of other proteins.
An earlier report indicated toxicity of dox at levels as low as 0.2 g/ml in PC-12 cells (10), although toxicity was not observed until 96 h after exposure of cells to dox. No cytotoxic effects of dox were observed on our rtTA2
S -M2-expressing clones of any of the three cell lines tested, over a 24-h period, which is the typical duration of our experiments, at concentrations up to 3 g/ml, i.e., generally above those found to be necessary for maximal heterologous gene expression.
The approach described here may provide a useful tool in drug discovery and development programs or for chemical toxicity studies. Idiosyncratic liver damage is a major problem in drug development because testing of inbred animals does not provide the variation in biochemical profile seen in the human population. Furthermore, toxicity test systems based on cell lines or even primary hepatocytes may not possess critical activation or defense pathways (33, 40) . Moreover, the difficulty in understanding the mechanisms underlying idiosyncratic hepatotoxicity is not just that there are no good animal models but that most humans are not good models (42) . Our approach is readily manipulable such that individuals at the extremes of the biochemical spectrum may be accurately modeled. Moreover, this system would be applicable to hepatotoxicity tests incorporating mutant forms of drug-activating or -metabolizing proteins, as well as highly variable levels of wild-type proteins.
In summary, we have produced hepatoma cell lines incorporating a dox-inducible gene regulation mechanism. These S -M2-HepG2 clone-using GSTP1 as the target gene. A HepG2 dox-inducible clone was stably transfected with a TRE-dependent human GSTP1 construct. Clones were selected with hygromycin, expanded, and tested for inducibility of GSTP1 expression. A suitable clone (HepG2-GSTP-WT2) was tested for inducibility over a 24-h period of induction (A) with dox (1 g/ml) at the level of protein expression, measured by Western blotting and GST activity, measured as 2,4-dinitrochlorobenzene-GSH conjugation. This clone was also tested for its response to increasing concentrations of dox (B) by measuring protein expression by Western blotting and GST activity. Similar Western data were obtained in 2 separate experiments. The activity data represent the mean Ϯ SD of 2 independent experiments. Fig. 7 . Proteomic analysis of a HepG2-tet on parental clone and HepG2-GSTP-WT2 reveals the lack of nonspecific effects of dox on the cell proteome, the capacity of this system for the cellular synthesis of large amounts of target protein, and the effect of GSTP1 expression on the global cell protein profile. HepG2-tet-on cells (A) and HepG2-GSTP-WT2 cells (B) were treated with 1 g/ml dox for 0, 4, and 24 h and analyzed by two-dimensional PAGE. the spot corresponding to GSTP1 is circled in bold. B: changes due to expression of GSTP1 are shown by the dotted circles and the boxes. Confirmation of the identity of the GSTP1 protein was achieved by spot excision, in-gel tryptic digestion, and liquid chromatography-electron spray ionization-MS/MS analysis. A summary of the Mascot MS/MS ion search, the sequence coverage, and the MS/MS spectrum for the amino-terminal peptide (marked with *) are shown in C.
Fig. 8. Stable regulatable expression is achievable in an rtTA2
S -M2-HepG2 clone by using NRF2 as the target gene. A HepG2 dox-inducible clone was stably transfected with a TRE-dependent murine NRF2 construct. Clones were selected with hygromycin, expanded, and tested for inducibility of NRF2 expression. A suitable clone (HepG2-NRF2-WT19) was tested for inducibility over a 48-h period of induction with dox (1 g/ml) at the level of protein expression, measured by Western blotting (A). The clone was also tested for its response to increasing concentrations of dox by measuring protein expression with Western blotting (B). HepG2-NRF2-WT19 was also induced with dox (1 g/ml) for 16 h, fixed, and permeabilized before confocal microscopy (C). Nuclei were stained with Hoechst 33258 to monitor the localization of the NRF2 induction and to aid in assessing the increase in NRF2. Expression of a gene known to be NRF2-dependent, glutamate cysteine ligase catalytic subunit (GCLC), was monitored in HepG2-NRF2-WT19 cell lysates relative to the levels of dox treatment for 16 h, using Western blot analysis employing a sheep anti-GCLC antibody and densitometric analysis of the intensity of the GCLC bands (D). The positive control was a sample of mouse liver homogenate. Similar results were obtained in further independent experiments. cells are amenable to the controlled expression of individual gene targets and should prove valuable physiological, pharmacological, and toxicological tools for defining the functional roles of proteins involved in liver cell biology.
